The propensity score-matched longitudinal study aimed to compare the efficacy of generic and brand-name formulations of levothyroxine in achieving and maintaining target thyrotropin levels. For ...

Patients diagnosed with hypothyroidism (almost all with benign disease) who were prescribed levothyroxine (L-T4) had similar rates of short-term cardiovascular events whether they received a branded ...

Synthroid was associated with an 11% lower likelihood of having TSH labs out of range when compared with similar patients taking generic levothyroxine. This article is written live from the American ...

Lupin has received the Food and Drug Administration’s nod for a new indication for levothyroxine sodium tablets. The product now is approved as a generic of King Pharmaceutical’s Levoxyl in dosage ...

New York (MedscapeWire) Aug 8 — Abbott Laboratories has submitted a New Drug Application (NDA) for levothyroxine sodium (Synthroid) to the US Food and Drug Administration (FDA), in advance of the ...

SAN FRANCISCO (CBS.MW) - The battle for market share of a drug used to treat a common thyroid problem intensified Wednesday after Abbott said its Synthroid was subject to competition by generics and ...